Aldeyra Therapeutics (ALDX) Non-Current Assets (2013 - 2026)
Aldeyra Therapeutics (ALDX) reported Non-Current Assets of $161,653 for Q2 2026, down 60.1% from $404,660 a year earlier and down 22.8% from the prior quarter.
Powered by 
Analysis
Aldeyra Therapeutics (ALDX) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Aldeyra Therapeutics posted Non-Current Assets of $275,861, down 48.4% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $534,216 in FY2024 (+3.4%), $516,578 in FY2023 (+92.4%), $268,544 in FY2022 (-30.1%) and $384,350 in FY2021 (+31.1%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets since Q3 2023.
- Year over year, Non-Current Assets has now declined in each of the last four quarters, with growth averaging 66.3% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q3 2024 (growth of 728.7%); the low point was Q3 2023 (a decline of 65.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $209,262 (Q1 2026), $275,861 (Q4 2025) and $340,977 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Aldeyra Therapeutics | 40.82 Mn | -214.61 Mn | - | 161,653.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 161,653.00 |
| Mar 31, 2026 | 209,262.00 |
| Dec 31, 2025 | 275,861.00 |
| Sep 30, 2025 | 340,977.00 |
| Jun 30, 2025 | 404,660.00 |
| Mar 31, 2025 | 466,942.00 |
| Dec 31, 2024 | 534,216.00 |
| Sep 30, 2024 | 598,589.00 |
| Jun 30, 2024 | 394,315.00 |
| Mar 31, 2024 | 455,946.00 |
| Dec 31, 2023 | 516,578.00 |
| Sep 30, 2023 | 72,233.00 |
| Jun 30, 2023 | 137,232.00 |
| Mar 31, 2023 | 201,572.00 |
| Dec 31, 2022 | 268,544.00 |
| Sep 30, 2022 | 208,603.00 |
| Jun 30, 2022 | 273,914.00 |
| Mar 31, 2022 | 337,926.00 |
| Dec 31, 2021 | 384,350.00 |
| Sep 30, 2021 | 445,621.00 |
API Access
Aldeyra Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ALDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ALDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ALDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();